Skip to content

Investigator

Meggan Mackay

FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · funded by NIAID

Companies
5

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$2.3M

Summed across those awards.

First award
Aug 1, 2008

Latest May 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P01

    Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE

    $133k

    May 1, 2025NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11406956 (opens the source filing in a new tab)

  2. P01

    Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE

    $91k

    May 1, 2025NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11406921 (opens the source filing in a new tab)

  3. P01

    Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE

    $845k

    May 9, 2024NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11086602 (opens the source filing in a new tab)

  4. P01

    Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLE

    $617k

    May 9, 2024NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11406920 (opens the source filing in a new tab)

  5. P01

    Assessing Brain Dysfunction in Individuals with SLE: Heterogeneity, Mechanisms and Metrics

    $573k

    Aug 1, 2008NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11113403 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources